Prereferral Head and Neck Cancer Treatment

Source: Archives of Otolaryngology- Head and Neck Surgery Objective To evaluate the prereferral treatment of patients referred to our tertiary care center with recurrent or persistent head and neck cancer for compliance with National Comprehensive Cancer Network (NCCN) guidelines. Design A prospective recruitment and retrospective chart review. Patients The study included new patients identified at multidisciplinary treatment planning conference from October 1, 2008, to February 1, 2009, who had received prior treatment at an outside institution and presented to our department with recurrent or persistent disease. Main Outcome Measures All facets of prior care were examined, including the time from initial symptoms to diagnosis and whether their prereferral treatment was compliant with or deviated from NCCN guidelines for head and neck cancer. Results A total of 566 consecutive new patients were identified, of whom 107 (18.9%) had persistent or recurrent disease. The average time from first presentation with initial symptoms to diagnosis among patients who presented with persistent disease was 23.8 weeks. Nearly half of the patients who presented with persistent or recurrent disease had either endocrine (21.5%) or cutaneous (24.2%) primary cancers, with the rest of the cases being distributed among 10 other sites. Of the patients who presented with recurrent or persistent disease, 43.0% had prereferral care that was noncompliant with NCCN guidelines. Of these patients, 58.7% had inadequate surgical management, 15.2% were treated for the wrong diagnosis, 10.9% received inadequate adjuvant therapy, 4.4% received inadequate radiotherapy, and 10.9% refused indicated recommended treatment. Conclusions Significant deviation from NCCN [...]

2010-12-22T11:28:19-07:00December, 2010|Oral Cancer News|

NCCN Panel: Straight talk with compassion urged for end-of-life cancer care

Source: www.medscape.com Author: Deborah Brauser Although telling patients that they have cancer and/or that the end is near is difficult, it should be handled in an informative, compassionate, individualized manner, according to a mainstage roundtable discussion here at the National Comprehensive Cancer Network (NCCN) 15th Annual Conference. The panel consisted of experts, celebrity survivors, family members of prominent people who lost their lives to cancer, and even a representative from one of the largest health insurance companies in the United States. "How do you tell a patient that the end is coming? And do they want to know?" asked moderator Sam Donaldson, veteran ABC News journalist, cancer survivor, and chair of the newly established NCCN Foundation Board of Directors. "I would say that about 90% of patients want to know the truth about what to expect, but they aren't statistics and they don't want to just hear statistics," answered David S. Ettinger, MD, professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine in Baltimore, Maryland. "I would recommend really communicating with patients and their families at their initial diagnosis and then design therapy for that particular individual," Dr. Ettinger added. "Everyone acts differently and every cancer is different, but you want to give them all hope, if possible." Kayce Freed Jennings, wife of the late news anchor Peter Jennings, said that she appreciated that the doctors never took away their hope until the final days. "While being realistic, we knew there were [...]

HPV-related cancer not confined to cervix

Source: www.businesswire.com Author: press release The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer. Expert physicians from the National Comprehensive Cancer Network (NCCN) Member Institutions presented an update on HPV and its link to various cancers including cervical cancer, anal carcinoma, and head and neck cancers discussing prevention strategies and the latest recommended treatment options according to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™). “It is important to counsel against any tobacco use as well as excessive alcohol consumption, and also to inform patients about the role of HPV and its mechanism of spread” Robert J. Morgan, MD, FACP of City of Hope Comprehensive Cancer Center and a member of the NCCN Guidelines Panel for Cervical Cancer began the session speaking about the link between HPV and cervical cancer as well as methods of prevention. “Cervical cancer screening with the pap smear is one of the greatest success stories in medicine,” said Dr. Morgan pointing to data that shows a steadily decreasing death rate from cervical cancer since the 1980s. The link between HPV and cervical cancer first started to emerge in the 1970’s when researchers found evidence linking cervical cancer to a wart virus coupled with the fact that cervical cancer was associated with sexual activity. In 1983, HPV DNA was identified in cervical cancer tissue. There are 120 known HPV serotypes with 19 being considered high risk, although as Dr. [...]

Go to Top